Anticytomegalovirus immunotoxin during ex vivo machine perfusion: Are we ready for cytomegalovirus-negative transplantation?

This publication has 5 references indexed in Scilit:

• Inhibition of cytomegalovirus reactivation by ex vivo treatment of human kidneys with the SYN002 immunotoxin
  American Journal of Transplantation, 2026
• The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
  Transplantation, 2025
• Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin
  The Journal of Heart and Lung Transplantation, 2022
• Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial
  The Lancet Respiratory Medicine, 2020
• Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo
  Proceedings of the National Academy of Sciences, 2015